Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004138 · ClinicalTrials.gov registry record · NA

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

A NA study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
NA
Development phase
303
Enrollment target
20
Study locations

NCT00004138 is a NA study of Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 303 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004138, a NA study of Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
NA
Development phase
303 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Imaging procedures, such as positron emission tomography (PET), may improve the ability to detect the extent of non-small cell lung cancer. PURPOSE: Diagnostic trial to study the effectiveness of PET for detecting lesions in patients who have newly diagnosed stage I, stage II, or stage IIIA non-small cell lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • RADIATION fludeoxyglucose F 18
  • PROCEDURE positron emission tomography
  • PROCEDURE radionuclide imaging

Study Locations (20)

Pennsylvania

  • Westmoreland Hospital - Greensburg
  • Jameson Memorial Hospital - New Castle
  • Allegheny General Hospital - Pittsburgh
  • Western Pennsylvania Cancer Institute - Pittsburgh

California

  • Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
  • UCSF Cancer Center and Cancer Research Institute - San Francisco

Florida

  • Morton Plant Mease Health Care - Clearwater
  • Lakeland Regional Medical Center - Lakeland

Illinois

  • University of Chicago Cancer Research Center - Chicago
  • Lutheran General Hospital - Park Ridge

Iowa

  • Holden Comprehensive Cancer Center - Iowa City
  • Veterans Affairs Medical Center - Iowa City - Iowa City

New York

  • Memorial Sloan-Kettering Cancer Center - New York
  • Mount Sinai School of Medicine - New York

Indiana

  • Indiana University Cancer Center - Indianapolis

Maryland

  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland - Baltimore

Trial Details

FieldValue
Enrollment Target 303 participants
Start Date 1999-09
Est. Completion 2002-12
Phase NA

Sponsor

Alliance for Clinical Trials in Oncology

446 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004138

The ClinicalTrials.gov registry entry for NCT00004138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which fludeoxyglucose F 18 is the first listed.

NCT00004138 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Pennsylvania, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00004138 about?

NCT00004138 is a clinical study titled "Positron Emission Tomography for Detecting Non-small Cell Lung Cancer". RATIONALE: Imaging procedures, such as positron emission tomography (PET), may improve the ability to detect the extent of non-small cell lung cancer. PURPOSE: Diagnostic trial to study the effectiveness of PET for detecting lesions in patients who have newly diagnosed stage I, stage II, or stage I...

What is the current status of trial NCT00004138?

This trial is currently completed. It is a NA study. The enrollment target is 303 participants. The study started on 1999-09. Estimated completion is 2002-12.

What conditions does trial NCT00004138 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00004138?

The interventions under investigation include: fludeoxyglucose F 18 (RADIATION), positron emission tomography (PROCEDURE), radionuclide imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00004138?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004138 being conducted?

This trial has 20 study locations across California, Florida, Illinois, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.